Literature DB >> 35449416

Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signaling.

Alejandro Moro1, Zhen Gao2, Lily Wang2,3,4, Aixin Yu1, Sunnie Hsiung1, Yuguang Ban2,3, Aimin Yan2, Corneliu M Sologon2, X Steven Chen2,3, Thomas R Malek5.   

Abstract

Regulatory T (Treg) cells require (interleukin-2) IL-2 for their homeostasis by affecting their proliferation, survival and activation. Here we investigated transcriptional and epigenetic changes after acute, periodic and persistent IL-2 receptor (IL-2R) signaling in mouse peripheral Treg cells in vivo using IL-2 or the long-acting IL-2-based biologic mouse IL-2-CD25. We show that initially IL-2R-dependent STAT5 transcription factor-dependent pathways enhanced gene activation, chromatin accessibility and metabolic reprogramming to support Treg cell proliferation. Unexpectedly, at peak proliferation, less accessible chromatin prevailed and was associated with Treg cell contraction. Restimulation of IL-2R signaling after contraction activated signature IL-2-dependent genes and others associated with effector Treg cells, whereas genes associated with signal transduction were downregulated to somewhat temper expansion. Thus, IL-2R-dependent Treg cell homeostasis depends in part on a shift from more accessible chromatin and expansion to less accessible chromatin and contraction. Mouse IL-2-CD25 supported greater expansion and a more extensive transcriptional state than IL-2 in Treg cells, consistent with greater efficacy to control autoimmunity.
© 2022. Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35449416      PMCID: PMC9106907          DOI: 10.1038/s41590-022-01179-1

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


  52 in total

Review 1.  Regulatory T cells in the treatment of disease.

Authors:  Amir Sharabi; Maria G Tsokos; Ying Ding; Thomas R Malek; David Klatzmann; George C Tsokos
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

2.  A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

3.  Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.

Authors:  Aixin Yu; Isaac Snowhite; Francesco Vendrame; Michelle Rosenzwajg; David Klatzmann; Alberto Pugliese; Thomas R Malek
Journal:  Diabetes       Date:  2015-01-09       Impact factor: 9.461

4.  IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells.

Authors:  Natasha C Ward; Aixin Yu; Alejandro Moro; Yuguang Ban; Xi Chen; Sunnie Hsiung; James Keegan; Jaren M Arbanas; Martine Loubeau; Anil Thankappan; Aaron P Yamniuk; Jonathan H Davis; Mary Struthers; Thomas R Malek
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

5.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Authors:  Aixin Yu; Linjian Zhu; Norman H Altman; Thomas R Malek
Journal:  Immunity       Date:  2009-01-29       Impact factor: 31.745

6.  The fate of interleukin-2 after in vivo administration.

Authors:  J H Donohue; S A Rosenberg
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

Review 7.  Control of regulatory T cell homeostasis.

Authors:  Maja Buszko; Ethan M Shevach
Journal:  Curr Opin Immunol       Date:  2020-08-15       Impact factor: 7.486

8.  Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms.

Authors:  Natasha C Ward; Jen Bon Lui; Rosmely Hernandez; Liping Yu; Mary Struthers; Jenny Xie; Alicia Santos Savio; Connor J Dwyer; Sunnie Hsiung; Aixin Yu; Thomas R Malek
Journal:  Diabetes       Date:  2020-08-25       Impact factor: 9.461

9.  Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape.

Authors:  Laurent Chorro; Masako Suzuki; Shu Shien Chin; Tere M Williams; Erik L Snapp; Livia Odagiu; Nathalie Labrecque; Grégoire Lauvau
Journal:  Nat Commun       Date:  2018-12-18       Impact factor: 14.919

10.  Essential and non-overlapping IL-2Rα-dependent processes for thymic development and peripheral homeostasis of regulatory T cells.

Authors:  Kevin H Toomer; Jen Bon Lui; Norman H Altman; Yuguang Ban; Xi Chen; Thomas R Malek
Journal:  Nat Commun       Date:  2019-03-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.